485 related articles for article (PubMed ID: 28780149)
1. Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.
Haghighijoo Z; Firuzi O; Hemmateenejad B; Emami S; Edraki N; Miri R
Bioorg Chem; 2017 Oct; 74():126-133. PubMed ID: 28780149
[TBL] [Abstract][Full Text] [Related]
2. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease.
Iraji A; Firuzi O; Khoshneviszadeh M; Nadri H; Edraki N; Miri R
Bioorg Chem; 2018 Apr; 77():223-235. PubMed ID: 29367079
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
Tarazi H; Odeh RA; Al-Qawasmeh R; Yousef IA; Voelter W; Al-Tel TH
Eur J Med Chem; 2017 Jan; 125():1213-1224. PubMed ID: 27871037
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
[TBL] [Abstract][Full Text] [Related]
7. Computational insights into β-site amyloid precursor protein enzyme 1 (BACE1) inhibition by tanshinones and salvianolic acids from Salvia miltiorrhiza via molecular docking simulations.
Yu T; Paudel P; Seong SH; Kim JA; Jung HA; Choi JS
Comput Biol Chem; 2018 Jun; 74():273-285. PubMed ID: 29679864
[TBL] [Abstract][Full Text] [Related]
8. The Identification of Biochanin A as a Potent and Selective β-Site App-Cleaving Enzyme 1 (Bace1) Inhibitor.
Youn K; Park JH; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2016 Oct; 8(10):. PubMed ID: 27754406
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, radiolabeling, and evaluation of a potent β-site APP cleaving enzyme (BACE1) inhibitor for PET imaging of BACE1 in vivo.
Pan L; He Q; Wu Y; Zhang N; Cai H; Yang B; Wang Y; Li Y; Wu X
Bioorg Med Chem Lett; 2022 Mar; 59():128543. PubMed ID: 35031452
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
Kumar A; Roy S; Tripathi S; Sharma A
J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
[TBL] [Abstract][Full Text] [Related]
11. BACE1 Inhibition by Genistein: Biological Evaluation, Kinetic Analysis, and Molecular Docking Simulation.
Youn K; Park JH; Lee S; Lee S; Lee J; Yun EY; Jeong WS; Jun M
J Med Food; 2018 Apr; 21(4):416-420. PubMed ID: 29444415
[TBL] [Abstract][Full Text] [Related]
12. Identification of new BACE1 inhibitors for treating Alzheimer's disease.
Kushwaha P; Singh V; Somvanshi P; Bhardwaj T; Barreto GE; Ashraf GM; Mishra BN; Chundawat RS; Haque S
J Mol Model; 2021 Jan; 27(2):58. PubMed ID: 33517514
[TBL] [Abstract][Full Text] [Related]
13. Carbazole-containing arylcarboxamides as BACE1 inhibitors.
Bertini S; Asso V; Ghilardi E; Granchi C; Manera C; Minutolo F; Saccomanni G; Bortolato A; Mason J; Moro S; Macchia M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6657-61. PubMed ID: 21986588
[TBL] [Abstract][Full Text] [Related]
14. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
[TBL] [Abstract][Full Text] [Related]
15. Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment.
Ugbaja SC; Sanusi ZK; Appiah-Kubi P; Lawal MM; Kumalo HM
Biophys Chem; 2021 Mar; 270():106536. PubMed ID: 33387910
[TBL] [Abstract][Full Text] [Related]
16. 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies.
Yan G; Hao L; Niu Y; Huang W; Wang W; Xu F; Liang L; Wang C; Jin H; Xu P
Eur J Med Chem; 2017 Sep; 137():462-475. PubMed ID: 28624701
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay.
Ju Y; Li Z; Deng Y; Tong A; Zhou L; Luo Y
Curr Comput Aided Drug Des; 2016; 12(1):73-82. PubMed ID: 26899408
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors.
Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P
Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
20. Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1).
Edraki N; Firuzi O; Foroumadi A; Miri R; Madadkar-Sobhani A; Khoshneviszadeh M; Shafiee A
Bioorg Med Chem; 2013 Apr; 21(8):2396-2412. PubMed ID: 23480856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]